PB

Pooja Bhatia

Active Director Director DIN 05133418
DIN 05133418 First appointment Nov 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2011
Shareholding value •••• Premium profile

About Pooja Bhatia

Data last updated:

Pooja Bhatia is a Director at Vardhman Biotech Private Limited (since 2011). The company operates in Pharma. Vardhman Biotech Private Limited reported revenue of ₹42.5 Lakh (FY 2025).

DIN 05133418
Primary Designation Director
Industry Pharma
First Appointment 02 Nov 2011
Oldest Company Age 21 yrs
Largest company Vardhman Biotech Private Limited · ₹42.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vardhman Biotech Private Limited U24232DL2004PTC131032
Director02 Nov 20112004₹42.5 Lakh (FY 2025)Active

Board colleagues of Pooja Bhatia

Directorship timeline

Open interactive timeline →
Vardhman Biotech Private Limited
Premium access

Shareholding and investment profile for Pooja Bhatia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pooja Bhatia

Pooja Bhatia currently holds 1 directorship: Vardhman Biotech Private Limited (Director, since 02 Nov 2011, revenue ₹42.5 Lakh (FY 2025)).

Pooja Bhatia was first appointed on 02 Nov 2011 as Director at Vardhman Biotech Private Limited.

The current boards of Pooja Bhatia's companies include Ajay Bhatia (Vardhman Biotech Private Limited), Ankur Bhatia (Vardhman Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available